The US Food and Drug Administration (FDA) has identified a limited number of benzoyl peroxide (BPO) acne products for retail-level recall because of elevated benzene levels, but more than 90% of ...
The FDA tested 95 products containing benzoyl peroxide, an ingredient widely used to treat acne that can form benzene as a byproduct. It found that six products could have more benzene than usual.
The FDA recently announced it is asking retailers to stop selling six acne medications, after a test showed increased levels of benzene.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results